David Johnson
2021 - Global Blood Therapeutics
Compensation breakdown
Non-Equity Incentive Plan | $178,000 |
---|---|
Option Awards | $1,102,132 |
Salary | $477,500 |
Stock Awards | $983,097 |
Other | $6,000 |
Total | $2,746,729 |
Johnson received $1.1M in option awards, accounting for 40% of the total pay in 2021.
Johnson also received $178K in non-equity incentive plan, $477.5K in salary, $983.1K in stock awards and $6K in other compensation.
Rankings
In 2021, David Johnson's compensation ranked 4,778th out of 12,415 executives tracked by ExecPay. In other words, Johnson earned more than 61.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 4,778 | 62nd |
Manufacturing | 1,993 | 64th |
Chemicals And Allied Products | 842 | 65th |
Drugs | 754 | 64th |
Pharmaceutical Preparations | 540 | 65th |
Pay ratio
David Johnson's Pay | $2,746,729 |
---|---|
Median Employee's Pay | $345,973 |
Pay Ratio | 8to 1 |
In 2021, the annual total compensation of David Johnson was $2,746,729.
The annual total compensation of the median employee at Global Blood Therapeutics was $345,973.
The ratio of David Johnson's pay to the pay of median employee was therefore 8 to one.
Johnson's colleagues
We found four more compensation records of executives who worked with David Johnson at Global Blood Therapeutics in 2021.